These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19216644)

  • 1. Modulation of the antifungal activity of new medicinal plant extracts active on Candida glabrata by the major transporters and regulators of the pleiotropic drug-resistance network in Saccharomyces cerevisiae.
    Kolaczkowski M; Kolaczkowska A; Stermitz FR
    Microb Drug Resist; 2009 Mar; 15(1):11-7. PubMed ID: 19216644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrates and modulators of the multidrug transporter Cdr1p of Candida albicans in antifungal extracts of medicinal plants.
    Kolaczkowski M; Kolaczkowska A; Sroda K; Ramalhete C; Michalak K; Mulhovo S; Ferreira MJ
    Mycoses; 2010 Jul; 53(4):305-10. PubMed ID: 19460101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
    Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STB5 is a negative regulator of azole resistance in Candida glabrata.
    Noble JA; Tsai HF; Suffis SD; Su Q; Myers TG; Bennett JE
    Antimicrob Agents Chemother; 2013 Feb; 57(2):959-67. PubMed ID: 23229483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
    Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D; Coste AT
    Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
    Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent functions of three Candida albicans zinc-cluster transcription factors (CTA4, ASG1 and CTF1) complementing pleiotropic drug resistance in Saccharomyces cerevisiae.
    Coste AT; Ramsdale M; Ischer F; Sanglard D
    Microbiology (Reading); 2008 May; 154(Pt 5):1491-1501. PubMed ID: 18451058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UPC2A is required for high-level azole antifungal resistance in Candida glabrata.
    Whaley SG; Caudle KE; Vermitsky JP; Chadwick SG; Toner G; Barker KS; Gygax SE; Rogers PD
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4543-54. PubMed ID: 24867980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.
    Tantivitayakul P; Lapirattanakul J; Kaypetch R; Muadcheingka T
    J Glob Antimicrob Resist; 2019 Jun; 17():221-226. PubMed ID: 30658200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
    Monk BC; Keniya MV; Sabherwal M; Wilson RK; Graham DO; Hassan HF; Chen D; Tyndall JDA
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida glabrata drug:H+ antiporter CgQdr2 confers imidazole drug resistance, being activated by transcription factor CgPdr1.
    Costa C; Pires C; Cabrito TR; Renaudin A; Ohno M; Chibana H; Sá-Correia I; Teixeira MC
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3159-67. PubMed ID: 23629708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vacuolar Sequestration of Azoles, a Novel Strategy of Azole Antifungal Resistance Conserved across Pathogenic and Nonpathogenic Yeast.
    Khandelwal NK; Wasi M; Nair R; Gupta M; Kumar M; Mondal AK; Gaur NA; Prasad R
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole resistance in Candida glabrata: coordinate upregulation of multidrug transporters and evidence for a Pdr1-like transcription factor.
    Vermitsky JP; Edlind TD
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3773-81. PubMed ID: 15388433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the multi-drug efflux systems of pathogenic fungi using functional hyperexpression in Saccharomyces cerevisiae.
    Niimi M
    Nihon Ishinkin Gakkai Zasshi; 2010; 51(2):79-86. PubMed ID: 20467195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milbemycins: more than efflux inhibitors for fungal pathogens.
    Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
    Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network.
    Kolaczkowski M; Kolaczowska A; Luczynski J; Witek S; Goffeau A
    Microb Drug Resist; 1998; 4(3):143-58. PubMed ID: 9818966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ATP-binding cassette transporter-encoding gene CgSNQ2 is contributing to the CgPDR1-dependent azole resistance of Candida glabrata.
    Torelli R; Posteraro B; Ferrari S; La Sorda M; Fadda G; Sanglard D; Sanguinetti M
    Mol Microbiol; 2008 Apr; 68(1):186-201. PubMed ID: 18312269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants.
    Tsai HF; Krol AA; Sarti KE; Bennett JE
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1384-92. PubMed ID: 16569856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.